Educational information, not medical advice — ask your doctor or midwife.
Hangeshashinto is a classical seven-herb Kampo formula whose roots trace back to the Chinese medical text Shang Han Lun (circa 200 CE). It was adopted into Japanese Kampo practice and is today one of the most rigorously studied traditional formulas in modern oncology settings. In Japan, it is commercially standardized and widely prescribed by physicians alongside conventional cancer treatment.
The formula works through several complementary pathways: its bitter alkaloids (from Coptis and Scutellaria) calm gut inflammation and inhibit bacterial overgrowth in the mouth and intestines, while ginger and Pinellia ease nausea by settling the stomach's signaling. Licorice and jujube add a soothing, protective quality to mucous membranes. Together, these herbs address what Kampo calls a 'hot-cold disharmony' in the digestive tract — essentially, an imbalance between inflammation and functional weakness.
In Japan, TJ-14 (Tsumura brand granules) is the most clinically studied and most commonly prescribed form. For oral mucositis specifically, granules dissolved in warm water and used as a gargle before swallowing appear to produce the best results — direct contact with mouth sores is considered part of the mechanism. Outside Japan, encapsulated extracts and raw decoction are available through specialty Kampo and TCM practitioners.
The formula originates from Zhang Zhongjing's Shang Han Lun, written around 200 CE during the Han Dynasty in China. It was brought to Japan alongside Chinese medicine and refined into the Kampo tradition over centuries. Today it remains one of the 148 Kampo formulas covered by Japan's national health insurance for prescription use, reflecting its integration into mainstream Japanese clinical practice.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.